Bayer AG - Company Profile
Powered by
All the data and insights you need on Bayer AG in one report.
- Save hours of research time and resources with
our up-to-date Bayer AG Strategy Report
- Understand Bayer AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Bayer AG (Bayer) carries out the discovery, development, manufacturing, and commercialization of products for human health, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology, and other indications. It also strives to develop new molecules and technologies for use in the fields of medicine and modern agriculture. The company's product portfolio includes prescription products, specialty pharmaceuticals, diagnostic imaging equipment, non-prescription (over-the-counter or OTC) products, seeds, crop protection solutions and non-agricultural pest control solutions. Bayer markets its products through wholesalers, pharmacies, hospitals, and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East. Bayer is headquartered in Leverkusen, North Rhine-Westphalia, Germany.
Bayer AG premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Product Categories:- | - | Xarelto |
Healthcare | Business - | Yasmin |
Prescription Drugs | IT Infrastructure and Applications | Yasminelle |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In May, the company announced a collaboration with Louis Dreyfus Company and Global Clean Energy Holdings to encourage camelina cultivation. |
2024 | Contracts/Agreements | In May, the company extended its partnership with Iberdrola to promote cleaner and more sustainable consumption in Italy. |
2024 | Regulatory Approval | In May, the company and its subsidiary BlueRock Therapeutics LP received Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration for BlueRock’s bemdaneprocel, an investigational cell therapy targeting Parkinson’s disease treatment. |
Competitor Comparison
Key Parameters | Bayer AG | Johnson & Johnson | BASF SE | F. Hoffmann-La Roche Ltd | Merck & Co Inc |
---|---|---|---|---|---|
Headquarters | Germany | United States of America | Germany | Switzerland | United States of America |
City | Leverkusen | New Brunswick | Ludwigshafen Am Rhein | Basel | Rahway |
State/Province | Nordrhein-Westfalen | New Jersey | Rheinland-Pfalz | - | New Jersey |
No. of Employees | 98,189 | 131,900 | 111,855 | 103,605 | 72,000 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
William N. Anderson | Chief Executive Officer | Senior Management | 2023 | 58 |
Wolfgang Nickl | Chief Financial Officer | Senior Management | 2018 | 55 |
Heike Prinz | Labor Director; Chief Talent Officer | Senior Management | 2023 | 60 |
Norbert Winkeljohann | Chairman | Non Executive Board | 2020 | 67 |
Ritu Mittal | Head - Marketing and Digital | Senior Management | 2023 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer